Sumatriptan transdermal iontophoretic patch (NP101-Zelrix™): review of pharmacology, clinical efficacy, and safety in the acute treatment of migraine
Michail Vikelis,1 Dimos D Mitsikostas,2 Alan M Rapoport31Glyfada Headache Center, Glyfada, Greece; 2Neurology Department, Athens Naval Hospital, Athens, Greece; 3The David Geffen School of Medicine at UCLA, Los Angeles, CA, USAAbstract: Migraine is a chronic, painful, and often disabling primary hea...
Main Authors: | Vikelis M, Mitsikostas DD, Rapoport AM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-09-01
|
Series: | Neuropsychiatric Disease and Treatment |
Online Access: | http://www.dovepress.com/sumatriptan-transdermal-iontophoretic-patch-np101-zelrixtrade-review-o-a11113 |
Similar Items
-
The iontophoretic transdermal system formulation of sumatriptan as a new option in the acute treatment of migraine: a perspective
by: Michail Vikelis, et al.
Published: (2015-07-01) -
Transdermal iontophoretic delivery of timolol maleate
by: Mayur Patni, et al.
Published: (2012-12-01) -
Iontophoretic and Microneedle Mediated Transdermal Delivery of Glycopyrrolate
by: Meera Gujjar, et al.
Published: (2014-12-01) -
PREVALENCE OF MENSTRUAL MIGRAINE AND THE EFFICACY OF SUMATRIPTAN ADMINISTRATION
by: Aldilla Afifie Putri Maidsky, et al.
Published: (2024-01-01) -
Efficacy of Sumatriptan/Placebo versus Sumatriptan/Propofol Combination in Acute Migraine; a Randomized Clinical Trial
by: Reza Farahmand Rad, et al.
Published: (2022-04-01)